Education
About Us
Working with TipRanks
Follow Us
Biosergen AB (DE:8N1)
FRANKFURT:8N1
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 0.00 | kr 0.00 | kr 0.00 | kr 8.57M | kr 4.43M |
| Gross Profit | kr 0.00 | kr -456.00K | kr -280.00K | kr 8.39M | kr -6.10M |
| Operating Income | kr -18.59M | kr -27.27M | kr -34.13M | kr -34.08M | kr -6.23M |
| EBITDA | kr -18.59M | kr 228.00K | kr -39.99M | kr 0.00 | kr -6.72M |
| Net Income | kr -18.79M | kr -27.04M | kr -33.91M | kr -34.56M | kr -7.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 50.61M | kr 1.88M | kr 29.34M | kr 21.66M | kr 589.00K |
| Total Assets | kr 52.85M | kr 7.20M | kr 33.79M | kr 29.49M | kr 4.80M |
| Total Debt | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| Net Debt | kr -50.61M | kr -1.88M | kr -29.34M | kr -21.66M | kr -589.00K |
| Total Liabilities | kr 3.71M | kr 5.08M | kr 11.00M | kr 9.25M | kr 15.72M |
| Stockholders' Equity | kr 49.14M | kr 2.12M | kr 22.79M | kr 20.23M | kr -10.92M |
| Cash Flow | |||||
| Free Cash Flow | kr -16.63M | kr -32.60M | kr -29.44M | kr -37.75M | kr -4.58M |
| Operating Cash Flow | kr -16.63M | kr -32.60M | kr -29.44M | kr -37.75M | kr -4.58M |
| Investing Cash Flow | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| Financing Cash Flow | kr 65.36M | kr 5.30M | kr 37.12M | kr 70.59K | kr 0.00 |
Biosergen AB Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.